Results of Phase I/II VMAT-TMI Dose Escalation Study Of Patients Undergoing Second Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Partouche, J. [1 ]
Hasan, Y. [2 ]
Sullivan, M. [3 ]
Yenice, K. M. [4 ]
Stock, W. [3 ]
Larson, R. [3 ]
Artz, A. [5 ]
Bishop, M. [3 ]
Kosuri, S. [3 ]
Kline, J. [3 ]
Riedell, P. [3 ]
Liu, H. [3 ]
Aydogan, B. [1 ]
机构：
[1] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
[2] Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[3] Univ Chicago Med, Chicago, IL USA
[4] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[5] City Hope Canc Ctr, Duarte, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3759
引用
收藏
页码：E757 / E757
页数：1
相关论文
共 50 条
  • [31] A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation
    Jessica Knight-Perry
    Cathryn Jennissen
    Susie E. Long
    Stefanie Hage
    Todd E. DeFor
    Wing T. Chan
    James Fisher
    Mark N. Kirstein
    Angela R. Smith
    Bone Marrow Transplantation, 2020, 55 : 955 - 964
  • [32] A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation
    Knight-Perry, Jessica
    Jennissen, Cathryn
    Long, Susie E.
    Hage, Stefanie
    DeFor, Todd E.
    Chan, Wing T.
    Fisher, James
    Kirstein, Mark N.
    Smith, Angela R.
    BONE MARROW TRANSPLANTATION, 2020, 55 (05) : 955 - 964
  • [33] A dose escalation study of total marrow irradiation (TMI) and autologous stem cell transplantation (ASCT) for the treatment of relapsed or refractory multiple myeloma
    Tay, J.
    Samant, R.
    Bredeson, C.
    Fraser, D.
    Atkins, H.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S202 - S203
  • [34] Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies
    Scheulen, ME
    Hilger, RA
    Oberhoff, C
    Casper, J
    F'reund, M
    Josten, KM
    Bornhäuser, M
    Ehninger, G
    Berdel, WE
    Baumgart, J
    Harstrick, A
    Bojko, P
    Wolf, HH
    Schindler, AE
    Seeber, S
    CLINICAL CANCER RESEARCH, 2000, 6 (11) : 4209 - 4216
  • [35] Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation
    Liu, Qifa
    Lin, Ren
    Fan, Zhiping
    Jiang, Qianli
    Dai, Min
    Sun, Jing
    BLOOD, 2014, 124 (21)
  • [36] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [37] A novel non-TBI conditioning regimen in 27 patients undergoing allogeneic bone marrow transplantation: Results of a phase I/II study.
    Agura, E
    Singh, S
    Pineiro, L
    Vance, E
    Fay, J
    BLOOD, 2001, 98 (11) : 184A - 184A
  • [38] A disease risk index for patients undergoing allogeneic stem cell transplantation
    Armand, Philippe
    Gibson, Christopher J.
    Cutler, Corey
    Ho, Vincent T.
    Koreth, John
    Alyea, Edwin P.
    Ritz, Jerome
    Sorror, Mohamed L.
    Lee, Stephanie J.
    Deeg, H. Joachim
    Storer, Barry E.
    Appelbaum, Frederick R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Kim, Haesook T.
    BLOOD, 2012, 120 (04) : 905 - 913
  • [39] Prevention of mucositis with KGF in patients undergoing allogeneic stem cell transplantation
    Goldberg, J. D.
    Zheng, J.
    Castro-Malaspina, H.
    Jakubowski, A. A.
    Heller, G.
    Van den Brink, M. R. M.
    Perales, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation
    Oshima, K.
    Kanda, Y.
    Kako, S.
    Ohno, K.
    Kishino, S.
    Kurokawa, M.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) : 323 - 327
12345